Treatment of Pediatric Female Yeast Infection

First-Line Treatment Options

The American Academy of Pediatrics recommends nystatin oral suspension (100,000 UI/mL) as a first-line treatment, administered 1 mL four times daily for 7-14 days for oral candidiasis (thrush) 1, 2
Miconazole oral gel has higher clinical cure rates (85.1%) compared to nystatin gels (42.8-48.5%) for oral candidiasis 1

Oral fluconazole is recommended for severe or recurrent infections, administered 3-6 mg/kg once daily for 7 days 1
Completing the full course of treatment is crucial, even if symptoms resolve earlier, to prevent recurrence 2

Nystatin oral suspension is administered 100,000 units (1 mL) three to four times daily for 7-10 days, and treatment should continue for at least 48 hours after symptoms resolve 1, 2
For young children, nystatin oral suspension can be applied directly to affected areas using a clean finger or cotton swab 2
Miconazole oral gel is an alternative treatment, administered 15 mg every 8 hours 1
Fluconazole oral is recommended for resistant cases, administered 3-6 mg/kg daily for 7 days 1

For breastfeeding-associated oral candidiasis, both mother and infant should be treated simultaneously, with the mother applying miconazole cream to nipples/areola after each feeding 1
For premature infants with weight <1000g in high-risk settings, consider prophylaxis with fluconazole (3-6 mg/kg twice weekly for 6 weeks) 1
Sterilizing pacifiers, bottles, and toys regularly during treatment can help prevent reinfection 2

The treatment endpoint should be mycological rather than just clinical cure 1
If infection persists or recurs, evaluate for underlying conditions that may predispose to candidiasis 2
Monitor for adverse effects, such as potential intestinal irritation in premature infants with nystatin 1

Treatment of maternal vaginal candidiasis prior to delivery may prevent subsequent neonatal colonization 3